InfluenzaArticle Published on 2022-08-272022-11-15 Journal: Lancet (London, England) [Category] [DOI] 10.1016/S0140-6736(22)00982-5 PMC 바로가기
Immunologic phenotype of patients with long-COVID syndrome of 1-year durationArticle Published on 2022-08-242022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.920627 PMC 바로가기
Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution급성 질환 해결 후 1~8개월 후 코로나19 환자의 장내 세균총 이상 감지Article Published on 2022-08-172022-09-11 Journal: International Journal of Environmental Research an [Category] [DOI] 10.3390/ijerph191610189 PMC 바로가기 [Article Type] Article
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021Observational Study Published on 2022-08-152022-10-04 Journal: The Medical journal of Australia [Category] [DOI] 10.5694/mja2.51619 PMC 바로가기 [Article Type] Observational Study
[Neuromuscular manifestations in long-COVID syndrome]Review Published on 2022-08-012023-07-10 Journal: Der Nervenarzt [Category] [DOI] 10.1007/s00115-022-01321-2 PMC 바로가기 [Article Type] Review
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study일본 참가자의 S-268019-b 또는 BNT162b2 추가 용량의 면역원성과 안전성: 2/3상, 무작위, 관찰자 맹검, 비열등성 연구의 중간 보고서Clinical Trial Published on 2022-07-302022-09-11 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.06.032 PMC 바로가기 [Article Type] Clinical Trial
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trialArticle Published on 2022-07-222022-10-06 Journal: EClinicalMedicine [Category] [DOI] 10.1016/j.eclinm.2022.101569 PMC 바로가기 [Article Type] Article
Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study한국 성인에서 Ad26.COV2.S의 면역원성과 반응성: 전향적 코호트 연구Article Published on 2022-07-112022-09-11 Journal: Journal of Korean medical science [Category] [DOI] 10.3346/jkms.2022.37.e210 PMC 바로가기 [Article Type] Article
Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort studyResearch article Published on 2022-07-012022-10-05 Journal: EClinicalMedicine [Category] [DOI] 10.1016/j.eclinm.2022.101542 [Article Type] Research article
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the USArticle Published on 2022-07-012022-10-06 Journal: JAMA Network Open [Category] [DOI] 10.1001/jamanetworkopen.2022.22241 PMC 바로가기 [Article Type] Article